acute angle
| indifferent oxide | An oxide that is neither an acid nor a base; e.g., water (hydrogen oxide, H2O). Synonym: indifferent oxide. (05 Mar 2000) |
|---|---|
| oxide | <chemistry> Any element (but especially a metal) that has formed a binary compound with oxygen. (09 Oct 1997) |
| tin oxide | SnO2;used in industry; it is a cause of pneumoconiosis. Synonym: tin oxide. (05 Mar 2000) |
| eserine oxide | An alkaloid from the seed of Physostigma; a parasympathomimetic agent. Synonym: eserine aminoxide, eserine oxide. (05 Mar 2000) |
| ethylene oxide | <chemical> Chemical name: Oxirane (12 Dec 1998) |
| ethyl oxide | CH3CH2OCH2CH3;a flammable, volatile organic solvent used in extraction procedures; formerly widely used as an inhalation anaesthetic; shortcomings include: irritating vapor, slow onset and prolonged recovery phase, explosion hazard. Synonym: ethyl ether, ethyl oxide, sulfuric ether. (05 Mar 2000) |
| zirconium oxide | Used as a coating for the skin in dermatologic pharmaceuticals and as a pigment in paints. (05 Mar 2000) |
| ferric oxide | A compound used as a colouring material. (05 Mar 2000) |
| 4-hydroxyaminoquinoline-1-oxide | <chemical> N-hydroxy-4-quinolineamine 1-oxide. A potent mutagen and carcinogen. It is a reduction product of 4-nitroquinoline-1-oxide. It binds with nucleic acids and inactivates both bacteria and bacteriophage. Pharmacological action: carcinogens, mutagens. Chemical name: 4-Quinolinamine, N-hydroxy-, 1-oxide (12 Dec 1998) |
| 4-nitroquinoline-1-oxide | <chemical> 4-nitroquinoline 1-oxide. A potent mutagen and carcinogen. This compound and its metabolite 4-hydroxyaminoquinoline-1-oxide bind to nucleic acids. It inactivates bacteria but not bacteriophage. Pharmacological action: carcinogens, mutagens. Chemical name: Quinoline, 4-nitro-, 1-oxide (12 Dec 1998) |
| 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | <chemical> 7,8,8a,9a-tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. A benzopyrene derivative with carcinogenic and mutagenic activity. Pharmacological action: carcinogens, mutagens. Chemical name: Benzo(10,11)chryseno(3,4-b)oxirene-7,8-diol, 7,8,8a,9a-tetrahydro- (12 Dec 1998) |
| lead oxide | Has been used as an ingredient in external applications such as lead plaster. Synonym: lead oxide (yellow), litharge, massicot. (05 Mar 2000) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| butter of zinc | ZnCl2;formerly used as a caustic for the removal of cutaneous cancers, nevi, etc., and in weak solution in the treatment of gonorrhoea and conjunctivitis. Synonym: butter of zinc. (05 Mar 2000) |
| globin zinc insulin | A sterile solution of insulin modified by the addition of zinc chloride and globin; it contains 40 or 80 units per ml; duration of action is about 18 hours. Human insulin, a protein that has the normal structure of insulin produced by the human pancreas, prepared by recombinant DNA techniques and by semisynthetic processes. Immunoreactive insulin (IRI), that portion of insulin in blood measured by immunochemical methods for the hormone; presumed to represent the free (unbound) and biologically active fraction of total blood insulin. Isophane insulin, a modified form of insulin composed of insulin, protamine, and zinc; an intermediately acting preparation used for the treatment of diabetes mellitus. Synonym: NPH insulin. (05 Mar 2000) |